Jochen Hefner

Oberduerrbacher Str, 6
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.

Journal: Journal of cancer research and clinical oncology

Published: April 03, 2020

Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center.

Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center.

Journal: Patient preference and adherence

Published: October 06, 2018

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy.

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy.

Journal: Journal of cancer research and clinical oncology

Published: August 09, 2018

New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.

New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.

Journal: Patient preference and adherence

Published: November 29, 2017

Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors.

Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors.

Journal: Oncology nursing forum

Published: October 21, 2017

The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Journal: Geburtshilfe und Frauenheilkunde

Published: October 21, 2016

Fear of Progression in Outpatients With Chronic Myeloid Leukemia on Oral Tyrosine Kinase Inhibitors.

Fear of Progression in Outpatients With Chronic Myeloid Leukemia on Oral Tyrosine Kinase Inhibitors.

Journal: Oncology nursing forum

Published: February 25, 2016

Recurrent Tako-Tsubo cardiomyopathy (TTC) in a pre-menopausal woman: late sequelae of a traumatic event?

Recurrent Tako-Tsubo cardiomyopathy (TTC) in a pre-menopausal woman: late sequelae of a traumatic event?

Journal: BMC cardiovascular disorders

Published: September 29, 2014

Stress and pancreatic carcinoma--β-adrenergic signaling and tumor biology

Stress and pancreatic carcinoma--β-adrenergic signaling and tumor biology

Journal: Deutsche medizinische Wochenschrift (1946)

Published: February 06, 2014

Stress management in females with Tako-Tsubo cardiomyopathy compared to females with acute coronary syndrome.

Stress management in females with Tako-Tsubo cardiomyopathy compared to females with acute coronary syndrome.

Journal: International journal of cardiology

Published: January 03, 2014

High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.

High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.

Journal: Bone marrow transplantation

Published: October 31, 2013

Unfavorable stress management strategies in patients with Tako-Tsubo cardiomyopathy (TTC).

Unfavorable stress management strategies in patients with Tako-Tsubo cardiomyopathy (TTC).

Journal: International journal of cardiology

Published: May 17, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026